Looking at the challenges and the true cost of NHS drug funding
Welcome!
This site aims to shed light on an increasingly controversial area of NHS policy in England and Wales, namely the process of deciding which new drug treatments will receive NHS funding.
With a wealth of costly drug treatments being promoted to improve the lives of patients with diseases such as cancer or mental health problems, and a limited pot of money, there are a lot of tough decisions to make.
This site will look at policy makers, patients and pharmaceutical companies as well as the doctors who deal with all three.
The patients
Click on the images below.
The National Institute for Health and Clinical Excellence is the organisation responsible for assessing drug treatments in England and Wales; here we try to assess NICE's methods.
Postcode variations in health care are still a major concern. Is NICE's guidance helping to bring more equality?
The British Pharmaceutical Industry
It's a major international force in medical innovation, but does the UK pharmaceutical industry use the media to manipulate NICE?
What options are there for the NHS and patients in the light of an increasing number of treatments arriving on the market?